The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum
Open accessAbstract
Proteolytic degradation of peptide-based drugs is often considered as major weakness limiting systemic therapeutic applications. Therefore, huge efforts are typically devoted to stabilize sequences against proteases present in serum or plasma, obtained as supernatants after complete blood coagulation or centrifugation of blood supplemented with anticoagulants, respectively. Plasma and serum are reproducibly obtained from animals and humans allowing consistent for clinical analyses and research applications. However, the spectrum of active or activated proteases appears to vary depending on the activation of proteases and cofactors during coagulation (serum) or inhibition of such enzymes by anticoagulants (plasma), such as EDTA (metallo- and Ca2+-dependent proteases) and heparin (e.g. thrombin, factor Xa). Here, we studied the presumed effects on peptide degradation by taking blood via cardiac puncture of CD-1 mice using a syringe containing a peptide solution. Due to absence of coagulation activators (e.g. glass surfaces and damaged cells), visible blood clotting was prevented allowing to study peptide degradation for one hour. The remaining peptide was quantified and the degradation products were identified using mass spectrometry. When the degradation rates (half-life times) were compared to serum derived freshly from the same animal and commercial serum and plasma samples, peptides of three different families showed indeed considerably different stabilities. Generally, peptides were faster degraded in serum than in plasma, but surprisingly all peptides were more stable in fresh blood and the order of degradation rates among the peptides varied among the six different incubation experiments. This indicates, that proteolytic degradation of peptide-based therapeutics may often be misleading stimulating efforts to stabilize peptides at degradation sites relevant only in vitro, i.e., for serum or plasma stability assays, but of lower importance in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,892
Overview of the coagulation system
Palta, S., Saroa, R., & Palta, A. (2014) · Indian Journal of Anaesthesia · doi:10.4103/0019-5049.144643 · Cited by 901
Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors
Rawlings, N. D., Barrett, A. J., & Finn, R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1118 · Cited by 687
Strategies to improve plasma half life time of peptide and protein drugs
Werle, M., & Bernkop-Schnürch, A. (2006) · Amino Acids · doi:10.1007/s00726-005-0289-3 · Cited by 660
Evolution of Proteolytic Enzymes
Neurath, H. (1984) · Science · doi:10.1126/science.6369538 · Cited by 644
Gentilucci, L., De Marco, R., & Cerisoli, L. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793292555 · Cited by 586
Differences between Human Plasma and Serum Metabolite Profiles
Yu, Z., Kastenmüller, G., He, Y., Belcredi, P., Möller, G., Prehn, C., Mendes, J., Wahl, S., Roemisch-Margl, W., Ceglarek, U., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021230 · Cited by 492
Apidaecins: antibacterial peptides from honeybees.
Casteels, P., Ampe, C., Jacobs, F., Vaeck, M., & Tempst, P. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08368.x · Cited by 469
The emergence of peptides in the pharmaceutical business: From exploration to exploitation
Uhlig, T., Kyprianou, T., Martinelli, F. G., Oppici, C. A., Heiligers, D., Hills, D., Calvo, X. R., & Verhaert, P. (2014) · EuPA Open Proteomics · doi:10.1016/j.euprot.2014.05.003 · Cited by 456
Blood Coagulation: Hemostasis and Thrombin Regulation
Tanaka, K. A., Key, N. S., & Levy, J. H. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31819bcc9c · Cited by 342
Fundamental Molecular Mechanism for the Cellular Uptake of Guanidinium-Rich Molecules
Herce, H. D., Garcia, A. E., & Cardoso, M. C. (2014) · Journal of the American Chemical Society · doi:10.1021/ja507790z · Cited by 258
Krizsan, A., Volke, D., Weinert, S., Sträter, N., Knappe, D., & Hoffmann, R. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201407145 · Cited by 253
Self-citationClinical Hematology: Theory and Procedures
Peterson, L. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/102.2.265 · Cited by 192
Clinical Hematology: Theory and Procedures
Turgeon, M. L. (1988) · Medical Entomology and Zoology · Cited by 159
Mojsoska, B., Zuckermann, R. N., & Jenssen, H. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00237-15 · Cited by 147
Knappe, D., Piantavigna, S., Hansen, A., Mechler, Á., Binas, A., Nolte, O., Martin, L. L., & Hoffmann, R. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100378b · Cited by 137
Self-citationCzihal, P., Knappe, D., Fritsche, S., Zahn, M., Berthold, N., Piantavigna, S., Müller, U., Dorpe, S. V., Herth, N., Binas, A., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb300063v · Cited by 121
Self-citationYi, J., Kim, C., & Gelfand, C. A. (2007) · Journal of Proteome Research · doi:10.1021/pr060550h · Cited by 111
Berthold, N., Czihal, P., Fritsche, S., Sauer, U., Schiffer, G., Knappe, D., Alber, G., & Hoffmann, R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01923-12 · Cited by 105
Self-citationEasy Strategy To Protect Antimicrobial Peptides from Fast Degradation in Serum
Knappe, D., Henklein, P., Hoffmann, R., & Hilpert, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00300-10 · Cited by 102
Self-citationHansen, A., Schäfer, I., Knappe, D., Seibel, P., & Hoffmann, R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00585-12 · Cited by 72
Self-citationRECENT ADVANCES IN HAEMOSTASIS AND THROMBOSIS
Vine, A. K. (2009) · Retina · doi:10.1097/iae.0b013e31819091dc · Cited by 63
Bactericidal oncocin derivatives with superior serum stabilities
Knappe, D., Kabankov, N., & Hoffmann, R. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.10.028 · Cited by 54
Self-citationReadily adaptable release kinetics of prodrugs using protease-dependent reversible PEGylation
Böttger, R., Knappe, D., & Hoffmann, R. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.010 · Cited by 42
Self-citationKarstad, R., Isaksen, G. V., Wynendaele, E., Guttormsen, Y., Spiegeleer, B. M. J. D., Brandsdal, B. O., Svendsen, J. S. M., & Svenson, J. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3002058 · Cited by 40
Gobbo, M., Benincasa, M., Bertoloni, G., Biondi, B., Dosselli, R., Papini, E., Reddi, E., Rocchi, R., Tavano, R., & Gennaro, R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900396a · Cited by 39
Murine Thrombin Lacks Na+ Activation but Retains High Catalytic Activity
Bush, L. A., Nelson, R. W., & Di, E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512082200 · Cited by 37
In vivo Efficacy and Pharmacokinetics of Optimized Apidaecin Analogs
Schmidt, R., Knappe, D., Wende, E., Ostorházi, E., & Hoffmann, R. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00015 · Cited by 36
Self-citationThrombin induces broad spectrum proteolysis in human serum samples
O'Mullan, P. J., Craft, D., Yi, J., & Gelfand, C. A. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.003 · Cited by 31
Sample collection in clinical proteomics—Proteolytic activity profile of serum and plasma
Jambunathan, K., & Galande, A. K. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300037 · Cited by 27
Watson, D. S., Jambunathan, K., Askew, D. S., Kodukula, K., & Galande, A. K. (2011) · BioTechniques · doi:10.2144/000113717 · Cited by 13
Cited by
Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity
Sæbø, I., Bjørås, M., Franzyk, H., Helgesen, E., & Booth, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032914 · Cited by 461
Antimicrobial Peptides: A Potent Alternative to Antibiotics
Rima, M., Rima, M., Fajloun, Z., Sabatier, J.-M., Bechinger, B., & Naas, T. (2021) · Antibiotics · doi:10.3390/antibiotics10091095 · Cited by 350
Meade, E., Slattery, M. A., & Garvey, M. (2020) · Antibiotics · doi:10.3390/antibiotics9010032 · Cited by 320
Preanalytical sample handling recommendations for Alzheimer's disease plasma biomarkers
Rózga, M., Bittner, T., Batrla, R., & Karl, J. (2019) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.02.002 · Cited by 99
Dermawan, D., & Alotaiq, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-93683-1 · Cited by 19
Metadata
- Authors
- Böttger, R., Hoffmann, R., & Knappe, D.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-06-02
- Volume
- 12
- Issue
- 6
- Pages
- e0178943
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2620755219
- Cited by
- 307
- References
- 31
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.